Memantine Hydrochloride Pinewood (Memantine Hydrochloride)

Memantine blocks the NMDA receptor’s ion channel in a non‑competitive manner, reducing excessive calcium influx that leads to excitotoxic neuronal damage. This modulation protects neurons while allowing normal synaptic activity, supporting cognitive function in Alzheimer’s disease.

The specific dose of Memantine Hydrochloride Pinewood is determined by the prescribing clinician based on the patient’s clinical condition, renal function, and tolerability. Dosage adjustments are made individually and should follow the prescriber’s instructions.

Safety data for memantine in pregnancy and lactation are limited. The product is classified as pregnancy category unknown, and it is not known whether it is excreted in breast milk. Use only if the potential benefit justifies the potential risk, and discuss with a healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Memantine belongs to the NMDA antagonist class, whereas other approved agents such as donepezil, rivastigmine, and galantamine are acetylcholinesterase inhibitors. Memantine is typically used in moderate to severe stages, often in combination with an acetylcholinesterase inhibitor for additive benefit.

Store Memantine Hydrochloride Pinewood tablets at ambient temperature below 25 °C. Keep the product in its original container, protect it from moisture, heat, and direct sunlight to maintain potency throughout its shelf life.

Memantine Hydrochloride Pinewood is taken orally, usually once or twice daily as directed by the prescriber. Tablets should be swallowed whole with water and can be taken with or without food, following the dosing schedule provided by the healthcare professional.

Serious risks include seizures, severe allergic reactions such as Stevens‑Johnson syndrome, hepatic dysfunction, cardiac arrhythmias, and emergence of suicidal thoughts. Patients should be monitored closely for any of these events and seek immediate medical attention if they occur.

Memantine is contraindicated in patients with known hypersensitivity to memantine or any of its excipients. Caution is advised for individuals with severe renal impairment, uncontrolled hypertension, or a history of seizures, and it should be avoided in pregnancy unless clearly indicated.